CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway

CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms

(2011) Jens Schittenhelm et al.   HISTOPATHOLOGY

In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine

(2010) Z. Li et al.   JNCI-Journal of the National Cancer Institute

Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis

(2010) Rola Al Dhaybi et al.   MODERN PATHOLOGY

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification

(2010) H Takenobu et al.   ONCOGENE

Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro

(2009) A. M. McCord et al.   MOLECULAR CANCER RESEARCH

Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents

(2009) Sharada D. Vangipuram et al.   PEDIATRIC BLOOD & CANCER

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

(2008) D Horst et al.   BRITISH JOURNAL OF CANCER

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

(2008) W. Song et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

(2008) Anastasia Murat et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype

(2008) B. Annabi et al.   MOLECULAR CANCER RESEARCH

Expression and clinical significance of stem cell marker CD133 in human neuroblastoma

(2008) Qiang-Song Tong et al.   World Journal of Pediatrics